GILD
HealthcareGilead Sciences, Inc.
Prev Close
$145.21
Open
$146.85
High
$148.22
Low
$144.24
Volume
2.58M
Market Cap
$180.27B
P/E
21.31
Div Yield
0.02%
Over the past 12 months, insider activity at Gilead Sciences, Inc. (GILD) has been exclusively selling, with 0 insider purchases totaling $0.00 and 27 insider sales totaling $60.44M. The most recent insider transaction was by O'Day Daniel Patrick (director, officer: Chairman & CEO), who sold $1.45M worth of shares on Mar 2, 2026. Gilead Sciences, Inc. operates in the Healthcare sector, within the Drug Manufacturers - General industry, with a market cap of $180.27B.
GILD Insider Trading Activity
GILD Insider Buying Activity
The following table shows recent insider purchases of Gilead Sciences, Inc. (GILD) stock reported via SEC Form 4 filings.
No insider buying activity found for GILD in the last 12 months.
GILD Insider Selling Activity
The following table shows recent insider sales of Gilead Sciences, Inc. (GILD) stock reported via SEC Form 4 filings.